Medsafe Logo


REGULATORY INFORMATION

Home  |  Consumers  |  Health Professionals  |  Regulatory  |  Other  |  Hot Topics  |  Search

Complementary Medicines

Permitted Ingredients List Project

The Permitted Ingredients List (PIL) project was commenced to assist the entry of the New Zealand complementary medicines industry into a joint therapeutic products regulatory environment with Australia. In July this year, the Government announced that work on establishing the Australia New Zealand Therapeutic Products Authority (ANZTPA) and the joint regulatory scheme had been placed on hold. Consequently work on progressing the PIL project was also placed on hold.

The project involved assessment of ingredients notified by sponsors of therapeutic-type dietary supplements. Where the ingredient is considered to be of low risk, by applying restrictions and label statements where necessary, it would be included in a list of ingredients that would be permitted for use in low risk (Class 1) medicines under the proposed ANZTPA scheme.

Although the project has been placed on hold, Medsafe has received a number of requests from the industry to provide feedback on the ingredients that had been notified.

The current status of ingredients notified for the PIL project is available on the ingredient status search facility below. This searchable database will be updated as new information becomes available.

Ingredient status search facility

Explanation of ingredient status

Unidentified Ingredients

Ingredient Identification Form
(Note this is a 77KB word document)
If you are unable to enter data into this form check the macro security in Word by choosing Tools, Options from the menu and clicking the Security tab. Click the "Macro Security" button and change the Security Level to Medium. When you open the document Word will have a message indicating the document contains macros. Click the "Enable Macros" button.

IJEACCM Reports and Minutes

Letter to Sponsors (Feb 2004)
(Note: This is a 56KB PDF file which requires Adobe Acrobat Reader to enable viewing - to download Adobe Acrobat Reader click here)